ReviewBMJ military health2025
Human augmentation to deliver an enhanced and resilient people capability for Defence.
Review in BMJ military health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Enhancing resilience in military personnel: insights into physiological, physical, psychological dimensions.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
From first tools, to flight, to advances in medicine and biotechnology, enhancing our innate abilities has been a constant goal and militaries the world over have long sought to advance the limits of human performance in their warfighters. Human augmentation (HA) encompasses a wide range of technologies that straddle a diversity of scientific disciplines and maturity levels, including wearable assistive technologies such as exoskeletons, neurotechnology, pharmacology, telexistence and genetics. Recent and rapid advances in life sciences and biotechnology and the convergence of fields such as artificial intelligence, robotics and medicine present us with a radically different opportunity for optimising and enhancing human performance. HA can be considered a potentially important strategy underpinning our ability to fight and win wars, by making soldiers more lethal and better able to survive. This paper is based on the HA thematic session held at the 6th International Congress on Soldiers' Physical Performance (ICSPP) in London in 2023. It considers aspects of HA of interest to participating nations and provides a state-of-the-art review of HA from a military perspective by experts engaged in this area. It considers the development of capability requirements, ethical, legal and social aspects and candidate HA technologies, one with ancient roots but modern applications for Defence (pharmacological augmentation) and one emerging area (non-invasive brain stimulation). HA offers a number of benefits, opportunities and challenges to the Defence community. Deployment of these technologies must take place within the boundaries of a nation's core values and beliefs, the rules-based international order and the freedoms that underpin their militaries' moral and ethical foundations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.